Literature DB >> 21382860

The efficacy and safety of fasciectomy and fasciotomy for Dupuytren's contracture in European patients: a structured review of published studies.

S M Crean1, R A Gerber, M P Hellio Le Graverand, D M Boyd, J C Cappelleri.   

Abstract

A structured review of published papers was done to assess the efficacy and safety of fasciectomy and fasciotomy in European patients with Dupuytren's contracture. The outcomes varied across 48 studies. For fasciectomy, outcomes and results were as follows: the proportions of patients with a 100% correction in contracture angle ranged from 61 to 97%, the mean improvement in contracture angle ranged from 58 to 79%, and cases judged excellent/good ranged from 63 to 90%. Fasciotomy had similar outcomes, with a mean improvement in contracture angle ranging from 46 to 88%. Immediate failures upon recovery were reported for both procedures. The average recurrence rates were 39% after a fasciectomy and 62% after a fasciotomy at a median time of about 4 years. Overall, about 20% of fasciectomy and fasciotomy patients experienced an adverse event. In summary, postoperative outcomes were successful, but surgical complications were common and recurrence of a contracture was likely within a few years.

Entities:  

Mesh:

Year:  2011        PMID: 21382860     DOI: 10.1177/1753193410397971

Source DB:  PubMed          Journal:  J Hand Surg Eur Vol        ISSN: 0266-7681


  21 in total

Review 1.  Dupuytren's disease: current state of the art.

Authors:  Mark Henry
Journal:  Hand (N Y)       Date:  2014-03

2.  Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: report of 40 cases.

Authors:  F Alberton; M Corain; A Garofano; L Pangallo; A Valore; V Zanella; R Adani
Journal:  Musculoskelet Surg       Date:  2013-11-20

3.  Examining the efficacy and maintenance of contracture correction after collagenase clostridium histolyticum treatment for Dupuytren's disease.

Authors:  Heather A McMahon; Abdo Bachoura; Sidney M Jacoby; David S Zelouf; Randall W Culp; A Lee Osterman
Journal:  Hand (N Y)       Date:  2013-09

4.  Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren's contracture.

Authors:  Nash H Naam
Journal:  Hand (N Y)       Date:  2013-12

Review 5.  Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice.

Authors:  Catherine Ball; Anna L Pratt; Jagdeep Nanchahal
Journal:  BMC Musculoskelet Disord       Date:  2013-04-10       Impact factor: 2.362

6.  Recent Surgical and Medical Advances in the Treatment of Dupuytren's Disease - A Systematic Review of the Literature.

Authors:  Mafi R; Hindocha S; Khan W
Journal:  Open Orthop J       Date:  2012-02-23

7.  Current trends in the surgical management of Dupuytren's disease in Europe: the surgeon's perspective.

Authors:  Lars B Dahlin; Christopher Bainbridge; Piotr P Szczypa; Joseph C Cappelleri; Daniel Guérin; Robert A Gerber
Journal:  Eur Orthop Traumatol       Date:  2012-03-02

8.  Current trends in the surgical management of Dupuytren's disease in Europe: an analysis of patient charts.

Authors:  Christopher Bainbridge; Lars B Dahlin; Piotr P Szczypa; Joseph C Cappelleri; Daniel Guérin; Robert A Gerber
Journal:  Eur Orthop Traumatol       Date:  2012-03-06

9.  Isolated and spontaneous correction of proximal interphalangeal joint contractures in Dupuytren's disease: an exploratory analysis of the efficacy and safety of collagenase Clostridium histolyticum.

Authors:  Michael J Hayton; Ardeshir Bayat; Douglass S Chapman; Robert A Gerber; Piotr P Szczypa
Journal:  Clin Drug Investig       Date:  2013-12       Impact factor: 2.859

10.  Costs for collagenase injections compared with fasciectomy in the treatment of Dupuytren's contracture: a retrospective cohort study.

Authors:  Isam Atroshi; Emelie Strandberg; Anna Lauritzson; Eva Ahlgren; Markus Waldén
Journal:  BMJ Open       Date:  2014-01-15       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.